| __timestamp | Ligand Pharmaceuticals Incorporated | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 74244000000 |
| Thursday, January 1, 2015 | 66107000 | 91739000000 |
| Friday, January 1, 2016 | 103402000 | 94597000000 |
| Sunday, January 1, 2017 | 135736000 | 94064000000 |
| Monday, January 1, 2018 | 245116000 | 94214000000 |
| Tuesday, January 1, 2019 | 108935000 | 101933000000 |
| Wednesday, January 1, 2020 | 156000000 | 106014000000 |
| Friday, January 1, 2021 | 214957000 | 117142000000 |
| Saturday, January 1, 2022 | 143418000 | 148506000000 |
| Sunday, January 1, 2023 | 96265000 | 196496000000 |
| Monday, January 1, 2024 | 245881000000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, Novo Nordisk A/S and Ligand Pharmaceuticals Incorporated present a fascinating study in contrasts. Over the past decade, Novo Nordisk has consistently demonstrated robust growth, with its gross profit soaring by approximately 165% from 2014 to 2023. This Danish giant, renowned for its diabetes care products, reached a staggering gross profit of nearly $197 billion in 2023.
Conversely, Ligand Pharmaceuticals, a smaller player in the industry, experienced more volatile growth. Despite a peak in 2018, where its gross profit surged by over 340% compared to 2014, Ligand's profits have since fluctuated, ending 2023 with a gross profit of around $96 million. This divergence highlights the varying strategies and market positions of these two companies, offering valuable insights into the dynamics of the pharmaceutical sector.
Key Insights on Gross Profit: Novo Nordisk A/S vs Sanofi
Gross Profit Comparison: Novo Nordisk A/S and United Therapeutics Corporation Trends
Gross Profit Analysis: Comparing Novo Nordisk A/S and Dr. Reddy's Laboratories Limited
Gross Profit Analysis: Comparing Novo Nordisk A/S and BioMarin Pharmaceutical Inc.
Novo Nordisk A/S and Catalent, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Novo Nordisk A/S vs Bausch Health Companies Inc.
Gross Profit Trends Compared: AbbVie Inc. vs Ligand Pharmaceuticals Incorporated
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
United Therapeutics Corporation vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated